The court underscored in an order that soldiers defend the country often in harsh and inhospitable conditions.

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension ...

Patients taking sotatercept had a 76% relative risk reduction in morbidity and mortality events compared with patients taking ...

The bench, headed by Justice C Hari Shankar and Justice Ajay Digpaul, observed that the disease and disability possibilities ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Eight specific habits — diet, sleep, physical activity, smoking, body mass index, blood glucose, lipids and blood pressure — ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...